Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. reports developments in AI-powered digital investigative and intelligence software for public and private sector customers. Its updates cover digital forensics, lawful device access, evidence analysis, investigative collaboration, application security and cloud deployment, including Cellebrite Government Cloud, Guardian Investigate, Genesis and Corellium.
Company news also includes federal cloud-security authorization, product releases, financial results, annual reporting, investor conference participation and product and technology leadership changes. Cellebrite’s software portfolio supports law enforcement agencies, defense and intelligence organizations, enterprises and service providers across cloud, on-premises and hybrid deployments.
Cellebrite (NASDAQ: CLBT) reported first-quarter 2026 revenue of $128.3 million, up 19% year-over-year, with subscription revenue of $117.9 million, up 23%. ARR reached $493 million, up 21%, and trailing 12‑month free cash flow was $158.6 million, a 32% margin.
GAAP net income was $10.9 million (EPS $0.04) and non-GAAP net income $30.6 million (EPS $0.12). The company closed its acquisition of SCG Canada, launched new AI-driven products, and guided 2026 ARR to $567–$573 million and revenue to $565–$571 million.
Cellebrite (NASDAQ: CLBT) announced management will participate in investor conferences in May–June 2026, including J.P. Morgan (May 18), TD Cowen (May 27), Craig-Hallum (May 28), William Blair (June 3), Mizuho (June 10) and D.A. Davidson (June 11).
Executives presenting include CEO Thomas Hogan and CFO David Barter; many sessions are fireside chats or 1x1 meetings and webcasts are available on the investor events page.
Cellebrite (Nasdaq: CLBT) announced that Cellebrite Government Cloud achieved FedRAMP High Authorization on May 6, 2026, with the U.S. Department of Justice as the authorizing agency.
The designation lists CGC on the FedRAMP Marketplace, enables DOJ component reuse and accelerates ATOs for other federal agencies, and covers Cellebrite Inseyets and Cellebrite Guardian for secure cloud-based digital forensics and evidence management.
Cellebrite (Nasdaq: CLBT) appointed Shiven Ramji as President, Products and Technology, effective May 4, 2026. Ramji will lead product and technology, succeeding Ronnen Armon, who will retire after a transition period. Ramji joins from Okta/Auth0, where he managed a $1 billion ARR business and held senior product roles at multiple tech firms.
The company said Ramji will drive AI adoption across Cellebrite's Digital Investigative and Intelligence platform and broaden product offerings to support customers.
Cellebrite (NASDAQ: CLBT) will report first-quarter 2026 financial results before U.S. markets open on Thursday, May 14, 2026.
The company will host a live conference call and webcast at 8:30 a.m. ET the same morning. Historical financial tables and supplemental data will be posted to the quarterly results section of the investor relations website.
Call details include conference ID CLBTQ126 and live webcast links for investors.
Cellebrite (Nasdaq: CLBT) awarded 20 JUSTYS at its second annual Digital Justice Awards on April 15, 2026, held during the C2C User Summit in Washington, D.C.
The event honored public- and private-sector digital investigators, featured keynotes including Terry Crews, and raised $67,500 from employees for C.O.P.S. survivor support.
Cellebrite (Nasdaq: CLBT) announced its Spring 2026 Release on March 31, 2026, expanding device access to the widest range of iOS and Android systems, including support for iPhone 17 and iOS 26. The release adds Safeguard Mode, drone forensics, and brings Corellium to Google Cloud (public preview) for Arm-based virtual testing.
Features aim to speed field data capture, broaden forensic sources, and let automakers virtually test vehicle software at scale in Google Cloud Axion C4A metal instances.
Cellebrite (NASDAQ: CLBT) announced Guardian Investigate, now generally available worldwide as of March 18, 2026. The AI-powered investigative management platform combines agentic AI, analytics and centralized case workflows to enable real-time evidence ingestion, collaborative case timelines, task management and maintained chain of custody across departments and agencies.
Guardian Investigate integrates with Guardian evidence management and complements Cellebrite Genesis for standalone rapid deployment.
Cellebrite (NASDAQ: CLBT) on March 16, 2026 launched Genesis, an agentic AI investigative platform now open for early access that aims to shorten investigative tasks from weeks to minutes.
Genesis analyzes phone extractions, CDRs, documents, images and video with claimed forensic-grade precision, integrates with existing Cellebrite tools, and adheres to NIST framework and SOC 2 standards. Cellebrite says nearly 3 million investigations annually and a customer base of over 7,000 support Genesis adoption; demonstrations planned at the C2C user conference.
Cellebrite (Nasdaq: CLBT) filed its Annual Report on Form 20-F for the year ended December 31, 2025 on March 4, 2026. The filing is available on the company's investor relations website and the U.S. SEC website. Shareholders can request a free hard copy by emailing investors@cellebrite.com.
References to external websites or social media do not constitute incorporation by reference into this release.